Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Weir

Showing results (271-280 of 1,221) with videos related to

Pageof 123
Sort By:
Kidney360|April 4, 2022
Hyperaldosteronism: How Current Concepts Are Transforming the Diagnostic and Therapeutic ParadigmMichael R Lattanzio, Matthew R Weir
Current Opinion in Nephrology and Hypertension|August 5, 2000
Theoretical basis and clinical evidence for differential effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor subtype 1 blockersM R Weir, W L Henrich
Current Opinion in Nephrology and Hypertension|February 24, 2001
Implications from the Heart Outcomes Prevention Evaluation StudyM R Weir, R C Blantz
The New Zealand Medical Journal|February 24, 2001
Influenza vaccination coverage in Canterbury rest homesR Weir, L Jennings, C Brunton
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 8, 1999
Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarctionW J Elliott, D R Weir
Inorganic Chemistry|October 24, 2001
Synthesis of Heteropolyoxometalate-Pillared Mg/Al, Mg/Ga, and Zn/Al Layered Double Hydroxides via LDH-Hydroxide PrecursorsMark R. Weir, Ronald A. Kydd
Heart (British Cardiac Society)|April 16, 2005
Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarctionR Weir, J J V McMurray
British Journal of Hospital Medicine|June 1, 1994
Staphylococcal infectionsB A Bovill, W R Weir
Military Medicine|February 1, 1984
GABHS infective endocarditis: case reportH S Patterson, M R Weir
Transplantation|April 23, 2009
Minimizing the risk of chronic allograft nephropathyMatthew R Weir, Ravinder K Wali
Pageof 123

Showing results (271-280 of 1,221) with videos related to

Sort By:
Pageof 123
Kidney360|April 4, 2022
Hyperaldosteronism: How Current Concepts Are Transforming the Diagnostic and Therapeutic ParadigmMichael R Lattanzio, Matthew R Weir
Current Opinion in Nephrology and Hypertension|August 5, 2000
Theoretical basis and clinical evidence for differential effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor subtype 1 blockersM R Weir, W L Henrich
Current Opinion in Nephrology and Hypertension|February 24, 2001
Implications from the Heart Outcomes Prevention Evaluation StudyM R Weir, R C Blantz
The New Zealand Medical Journal|February 24, 2001
Influenza vaccination coverage in Canterbury rest homesR Weir, L Jennings, C Brunton
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 8, 1999
Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarctionW J Elliott, D R Weir
Inorganic Chemistry|October 24, 2001
Synthesis of Heteropolyoxometalate-Pillared Mg/Al, Mg/Ga, and Zn/Al Layered Double Hydroxides via LDH-Hydroxide PrecursorsMark R. Weir, Ronald A. Kydd
Heart (British Cardiac Society)|April 16, 2005
Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarctionR Weir, J J V McMurray
British Journal of Hospital Medicine|June 1, 1994
Staphylococcal infectionsB A Bovill, W R Weir
Military Medicine|February 1, 1984
GABHS infective endocarditis: case reportH S Patterson, M R Weir
Transplantation|April 23, 2009
Minimizing the risk of chronic allograft nephropathyMatthew R Weir, Ravinder K Wali
Pageof 123